SMYD3 Promotes Immune Evasion in Clear Cell Renal Cell Carcinoma via SREBP1-Mediated Transactivation of CD47

Zhengfang Liu1,2,3, Xiumei Zhao4, Maolin Zang2

  • 1Thoracic Surgery Department, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan, 250117, China.

Insights

Dysregulation of SMYD3 in clear cell renal cell carcinoma (ccRCC) creates an immunosuppressive tumor microenvironment. This impairs PD-1 blockade response by promoting T helper 2 cell infiltration via the SMYD3-SREBP1-CD47 axis.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Cancer cell-intrinsic features significantly influence the tumor immune microenvironment and immunotherapy response.
  • Clear cell renal cell carcinoma (ccRCC) exhibits complex interactions between tumor cells and immune cells.
  • Understanding these interactions is crucial for developing effective cancer therapies.

Purpose of the Study:

  • To investigate the role of SET and MYND domain-containing protein 3 (SMYD3) in ccRCC immunity.
  • To elucidate the molecular mechanisms by which SMYD3 regulates the tumor immune microenvironment.
  • To identify potential therapeutic targets for enhancing immunotherapy in ccRCC.

Main Methods:

  • Analysis of cancer cell-intrinsic features and immune cell infiltration in ccRCC.
  • Investigating the interaction between SMYD3, Sp1, sterol regulatory element-binding protein 1 (SREBP1), and CD47.
  • Assessing the impact of the SMYD3-SREBP1-CD47 axis on T helper 2 cell infiltration and PD-1 blockade response.

Main Results:

  • Dysregulated SMYD3 orchestrates an immunosuppressive microenvironment in ccRCC.
  • SMYD3 cooperates with Sp1 to upregulate SREBP1 and subsequently CD47 expression.
  • The SMYD3-SREBP1-CD47 axis promotes T helper 2 cell infiltration, hindering anti-tumor immunity and PD-1 blockade efficacy.

Conclusions:

  • The SMYD3-SREBP1-CD47 axis is a critical regulator of the immune microenvironment in ccRCC.
  • Targeting this axis offers a potential strategy to enhance anti-tumor immunity and improve immunotherapy outcomes in ccRCC.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K